METRONIDAZOLE
AUROBINDO PHARMA LTD · METRONIDAZOLE
Open FDA's page for this record- Application number
- ANDA218485
- Sponsor name
- AUROBINDO PHARMA LTD
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260925
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- METRONIDAZOLE
- Reference standard
- No
- Dosage form
- GEL
- Route
- VAGINAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- METRONIDAZOLE
- Strength
- 0.75%
- Harmonized identifiers (openFDA)
- Application number
- ANDA218485
- Brand name
- METRONIDAZOLE VAGINAL GEL
- Generic name
- METRONIDAZOLE
- Manufacturer name
- Aurobindo Pharma Limited
- Product NDC
- 59651-703
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- VAGINAL
- Substance name
- METRONIDAZOLE
- RxCUI
- 142046
- SPL ID
- 2ced2460-a003-4314-897b-f4ae0ff72edf
- SPL set ID
- 2ced2460-a003-4314-897b-f4ae0ff72edf
- Package NDC
- 59651-703-70
- Nui
- N0000175435, M0014907
- Pharm class epc
- Nitroimidazole Antimicrobial [EPC]
- Pharm class cs
- Nitroimidazoles [CS]
- UNII
- 140QMO216E
